{
  "nct_id": "NCT04725903",
  "official_title": "Extended-Field Lymph Node Proton Irradiation for High Risk Prostate Cancer",
  "brief_title": "Proton Radiation Therapy for the Treatment of Patients with High Risk Prostate Cancer",
  "cancer_type_display": "A study of proton radiation therapy for patients with high-risk or lymph node positive prostate cancer.",
  "cancer_tags": [
    "Stage III Prostate Cancer AJCC V8",
    "Stage IIIA Prostate Cancer AJCC V8",
    "Stage IIIB Prostate Cancer AJCC V8",
    "Stage IIIC Prostate Cancer AJCC V8"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT04725903",
  "phase": "NA",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2024-11-14",
  "enrollment": 30,
  "min_age": 18,
  "max_age": null,
  "sex": "MALE",
  "is_metastatic_allowed": false,
  "performance_status_scale": "Zubrod",
  "performance_status_values": [
    0,
    1,
    2
  ],
  "min_prior_lines": null,
  "max_prior_lines": null,
  "prior_treatments_required": null,
  "prior_treatments_excluded": [
    "Previous radical surgery (prostatectomy)",
    "Cryosurgery for prostate cancer",
    "Prior radiotherapy to the region of the study cancer"
  ],
  "principal_investigator": "Pretesh R Patel",
  "site_name": "Emory University Hospital/Winship Cancer Institute",
  "contact_email": "pretesh.patel@emory.edu",
  "contact_phone": "404-778-3473",
  "locations": [
    {
      "facility": "Emory University Hospital/Winship Cancer Institute",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "Ardith R. DeShay",
          "role": "CONTACT",
          "phone": "404-686-1858",
          "email": "adeshay@emory.edu"
        },
        {
          "name": "Pretesh R. Patel, MD",
          "role": "CONTACT"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    }
  ],
  "key_inclusion_summary": [
    "Pathologically confirmed high-risk prostate cancer (Gleason grade ≥ 8, cT3b/cT4, PSA > 20, or positive regional lymph nodes).",
    "Zubrod performance status of 0-2.",
    "Adequate blood counts (ANC ≥ 1,500 cells/mm³, Platelets ≥ 100,000 cells/mm³, Hemoglobin ≥ 8.0 g/dl).",
    "Able to provide study-specific informed consent."
  ],
  "key_exclusion_summary": [
    "Presence of bone or distant lymph node metastasis.",
    "Previous radical surgery (prostatectomy) or cryosurgery for prostate cancer.",
    "Prior radiotherapy to the region of the study cancer that would result in overlap of radiation fields.",
    "Uncontrolled intercurrent illness, including inflammatory bowel disease."
  ]
}